Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder

Journal of Cardiovascular Translational Research

Volumn 5, Issue 1, 2012, Pages 92-99

  Jiang, Wei ^a   Oken, Harry ^b   Fiuzat, Mona ^a   Shaw, Linda K ^c   Martsberger, Carolyn ^a   Kuchibhatla, Maragatha ^a   Kaddurah Daouk, Rima ^a   Steffens, David C ^a   Baillie, Rebecca ^d   Cuffe, Michael ^a   Krishnan, Ranga ^a,e   O'Connor, Christopher ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Martek Biosciences Corporation   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d Rosa and Co LLC   (United States)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Depression; Heart failure; Omega 3 fatty acids; Prognosis

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID ESTER; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HEART DEATH; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DEPRESSIVE DISORDER, MAJOR; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FATTY ACIDS, OMEGA-3; FEMALE; FLAME IONIZATION; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SERTRALINE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 84859793301     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-011-9325-8     Document Type: Article

References (59)

1. Albert, C. M., Hennekens, C. H., O'Donnell, C. J., et al. (1998). Fish consumption and risk of sudden cardiac death. Journal of the American Medical Association, 279(1), 23-28. (Pubitemid 28070546)
2. Kromhout, D., Bosschieter, E. B., & Coulander, C. D. (1985). The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New England Journal of Medicine, 312(19), 1205-1209. (Pubitemid 15009153)
3. Lavie, C. J., & Milani, R. V. (1996). Fish oils. In F. H. Messerli (Ed.), Cardiovascular drug therapy (pp. 1608-1613). Philadelphia: Saunders.
4. Lee, J. H., O'Keefe, J. H., Lavie, C. J., Marchioli, R., & Harris, W. S. (2008). Omega-3 fatty acids for cardioprotection. Mayo Clinic Proceedings, 83(3), 324-332. (Pubitemid 351469243)
5. Yokoyama, M., Origasa, H., Matsuzaki, M., et al. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised openlabel, blinded endpoint analysis. Lancet, 369(9567), 1090-1098. (Pubitemid 46483662)
6. Valagussa, F., Franzosi, M. G., Geraci, E., et al. (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet, 354(9177), 447-455.
7. Harris, W. S., Mozaffarian, D., Rimm, E., et al. (2009). Omega-6 fatty acids and risk for cardiovascular disease a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation, 119(6), 902-907. doi:10.1161/ circulationaha.108.191627.
8. Kris-Etherton, P. M., Harris, W. S., Appel, L. J., & Nutr, C. (2003). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arteriosclerosis Thrombosis and Vascular Biology, 23(2), E20-E31. doi:10.1161/01.atv.0000038493.65177.94.
9. Lichtenstein, A. H., Appel, L. J., Brands, M., et al. (2006). Diet and lifestyle recommendations revision 2006-A scientific statement from the American Heart Association Nutrition Committee. Circulation, 114(1), 82. doi:10.1161/circulationaha.106.176158.
10. Tavazzi, L., Maggioni, A. P., Marchioli, R., et al. (2008). Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet, 372(9645), 1223-1230. doi:10.1016/s0140-6736(08)61239-8.
11. Jiang, W., O'Connor, C., Silva, S. G., et al. (2008). Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. American Heart Journal, 156(3), 437-444. doi:10.1016/j.ahj.2008.05.003.
12. O'Connor, C. M., Jiang, W., Kuchibhatla, M., et al. (2010). Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF trial. Journal of the American College of Cardiology, 56(9), 692-699.
13. Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67(3), 588-597. (Pubitemid 26382973)
14. Bailey-Hall, E., Nelson, E. B., & Ryan, A. S. (2008). Validation of a rapid measure of blood PUFA levels in humans. Lipids, 43(2), 181-186. doi:10.1007/s11745-007-3140-7.
15. Lands, W. E. M. (2003). Functional foods in primary prevention or nutraceuticals in secondary prevention? Current Topics in Nutraceutical Research, 1, 113-119.
16. Paganelli, F., Maixent, J. M., Duran, M. J., Parhizgar, R., Pieroni, G., & Sennoune, S. (2001). Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Int J Cardiol, 78(1), 27-32. (Pubitemid 32232134)
17. Rissanen, T., Voutilainen, S., Nyyssonen, K., Lakka, T. A., & Salonen, J. T. (2000). Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events-the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation, 102(22), 2677-2679.
18. Rupp, H., Wagner, D., Rupp, T., Schulte, L. M., & Maisch, B. (2004). Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio"-Focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Herz, 29(7), 673-685. doi:10.1007/s00059-004- 2602-4. (Pubitemid 40064639)
19. Siscovick, D. S., Raghunathan, T. E., King, I., et al. (1995). Dietaryintake and cell-membrane levels of long-chain n-3 polyunsaturated fatty-acids and the risk of primary cardiac-arrest. JAMA: The Journal of the American Medical Association, 274(17), 1363-1367.
20. Harris, W. S., Poston, W. C., & Haddock, C. K. (2007). Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis, 193(1), 1-10. doi:10.1016/j.atherosclerosis.2007. 03.018.
21. Mori, T. A., & Woodman, R. J. (2006). The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Current Opinion in Clinical Nutrition and Metabolic Care, 9(2), 95-104. (Pubitemid 44090031)
22. Wilhelm, M., Tobias, R., Asskali, F., et al. (2008). Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. American Heart Journal, 155(6), 971-977. doi:10.1016/j.ahj.2007. 11.045.
23. Frasure-Smith, N., Lesperance, F., & Julien, P. (2004). Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biological Psychiatry, 55(9), 891-896. doi:10.1016/j.biopsych.2004.01. 021S0006322304001076.
24. Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry, 43(5), 315-319. (Pubitemid 28137622)
25. Edwards, R., Peet, M., Shay, J., & Horrobin, D. (1998). Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders, 48(2-3), 149-155. (Pubitemid 28244216)
26. Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., & Meltzer, H. Y. (1999). Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research, 85(3), 275-291. (Pubitemid 29202389)
27. Mamalakis, G., Jansen, E., Cremers, H., Kiriakakis, M., Tsibinos, G., & Kafatos, A. (2006). Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. European Journal of Clinical Nutrition, 60(8), 1016-1023. doi:10.1038/sj.ejcn. 1602413.
28. McNamara, R. K., Hahn, C. G., Jandacek, R., et al. (2007). Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biological Psychiatry, 62(1), 17-24. doi:10.1016/j.biopsych.2006.08.026. (Pubitemid 46898224)
29. Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996). Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders, 38(1), 35-46.
30. Tiemeier, H., van Tuijl, H. R., Hofman, A., Kiliaan, A. J., & Breteler, M. M. B. (2003). Plasma fatty acid composition and depression are associated in the elderly: The Rotterdam Study. American Journal of Clinical Nutrition, 78(1), 40-46. (Pubitemid 39655246)
31. Feart, C., Peuchant, E., Letenneur, L., et al. (2008). Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: Data from the Bordeaux sample of the Three-City Study. American Journal of Clinical Nutrition, 87(5), 1156-1162. (Pubitemid 351679753)
32. Tang, W. H. W., & Samara, M. A. (2011). Polyunsaturated Fatty acids in heart failure: Should we give more and give earlier? Journal of the American College of Cardiology, 57(7), 880-883.
33. Calder, P. C. (1998). Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Brazilian Journal of Medical and Biological Research, 31(4), 467-490.
34. Heller, A. T. J., & Koch, T. (2003). Fish or chips? News in Physiological Sciences, 18, 50-54.
35. Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56(8), 365-379.
36. Christensen, J. H., Christensen, M. S., Dyerberg, J., & Schmidt, E. B. (1999). Heart rate variability and fatty acid content of blood cell membranes: A dose-response study with n-3 fatty acids. American Journal of Clinical Nutrition, 70(3), 331-337. (Pubitemid 29407152)
37. Ghio, S., Scelsi, L., Latini, R., et al. (2010). Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: A substudy of GISSI-HF trial. European Journal of Heart Failure: Journal of the Working Group on Heart Failure of the European Society of Cardiology, 12(12), 1345-1353.
38. Nodari, S., Triggiani, M., Campia, U., et al. (2011). Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology, 57(7), 870-879.
39. Lin, P. Y., & Su, K. P. (2007). A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. The Journal of Clinical Psychiatry, 68(7), 1056-1061.
40. Richardson, A. J. (2008). n-3 fatty acids and mood: The devil is in the detail. British Journal of Nutrition, 99(2), 221-223. doi:10.1017/ s0007114507824123.
41. Ross, B. M. (2008). The emerging role of eicosapentaenoic acid as an important psychoactive natural product: Some answers but a lot more questions. Lipid Insights, 2, 98-7.
42. Burdge, G. C., & Wootton, S. A. (2002). Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. British Journal of Nutrition, 88 (4), 411-420. doi:10.1079/bjn2002689. (Pubitemid 35251957)
43. Burdge, G. C., & Calder, P. C. (2005). Conversion of alphalinolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development, 45(5), 581-597. doi:10.1051/rnd:2005047. (Pubitemid 41511883)
44. Burdge, G. C., Jones, A. E., & Wootton, S. A. (2002). Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. British Journal of Nutrition, 88(4), 355-363. doi:10.1079/bjn2002662. (Pubitemid 35251952)
45. Arterburn, L. M., Hall, E. B., & Oken, H. (2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. American Journal of Clinical Nutrition, 83(6), 1467S-1476S. (Pubitemid 44713087)
46. Cho, H. P., Nakamura, M., & Clarke, S. D. (1999). Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. Journal of Biological Chemistry, 274(52), 37335-37339.
47. Xie LaI, S. M. (2010). Association of fatty acid desaturase gene polymorphisms with blood lipid essential fatty acids and perinatal depression among Canadian women: a pilot study. Journal of Nutrigenetics and Nutrigenomics, 2(4-5), 243-250.
48. Lalovic, A., Klempan, T., Sequeira, A., Luheshi, G., & Turecki, G. (2010). Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. Journal of Affective Disorders, 120(1-3), 24-31. doi:10.1016/j.jad.2009. 04.007.
49. BoltonSmith, C., Woodward, M., & Tavendale, R. (1997). Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. European Journal of Clinical Nutrition, 51(9), 619-624.
50. Bordoni, A., Biagi, P. L., Turchetto, E., & Hrelia, S. (1988). Aging influence on delta-6-desaturase activity and fatty-acid composition of rat-liver microsomes. Biochemistry International, 17(6), 1001-1009. (Pubitemid 19031946)
51. Bourre, J. M., & Piciotti, M. (1997). Alterations in eighteen-carbon saturated, monounsaturated and polyunsaturated fatty acid peroxisomal oxidation in mouse brain during development and aging. Biochemistry and Molecular Biology International, 41(3), 461-468. (Pubitemid 27154125)
52. Hrelia, S., Bordoni, A., Celadon, M., Turchetto, E., Biagi, P. L., & Rossi, C. A. (1989). Age-related-changes in linoleate and alpha-linolenate desaturation by rat-liver microsomes. Biochemical and Biophysical Research Communications, 163(1), 348-355. (Pubitemid 19227312)
53. Maniongui, C., Blond, J. P., Ulmann, L., Durand, G., Poisson, J. P., & Bezard, J. (1993). Age-related-changes in delta-6 and delta-5 desaturase activities in rat-liver microsomes. Lipids, 28(4), 291-297. (Pubitemid 23111154)
54. Perichon, R., & Bourre, J. M. (1995). Peroxisomal beta-oxidation activity and catalase activity during development and aging in mouse-liver. Biochimie, 77(4), 288-293.
55. Appleton, K. H. R., Gunnell, D., Peters, T., Rogers, P., Kessler, D., & Ness, A. (2006). Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systemic review of published trials. American Journal of Clinical Nutrition, 84, 1308-1316. (Pubitemid 44912811)
56. Appleton, K. M., Rogers, P. J., & Ness, A. R. (2010). Updated systematic review and meta-analysis of the effects of n-3 longchain polyunsaturated fatty acids on depressed mood. American Journal of Clinical Nutrition, 91(3), 757-770. doi:10.3945/ajcn.2009.28313.
57. Carney, R. M., Freedland, K. E., & Steinmeyer, B. C. (2010). Omega-3 fatty acids for CHD with depression reply. Jama- Journal of the American Medical Association, 303(9), 836.
58. Lesperance, F., Frasure-Smith, N., St-Andre, E., Turecki, G., Lesperance, P., & Wisniewski, S. R. (2010). The efficacy of omega-3 supplementation for major depression: A randomized controlled trial. The Journal of Clinical Psychiatry. doi:10.4088/JCP.10m05966blu.
59. Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010). n-3 Fatty acids and cardiovascular events after myocardial infarction. The New England Journal of Medicine. doi:10.1056/NEJMoa 1003603.